New ISCB Course on Adaptive Design

Posted by Esha Senchaudhuri

Aug 19, 2014 8:48:00 AM


Biostatisticians from Cytel will be delivering a course on adaptive designs at this year’s International Society for Clinical Biostatistics. The course will help attendees develop strategies for interim decision-making, by providing an overview of recent advances in statistical methodology and applying them to case studies in oncology and cardiology

Members of Cytel Consulting are not only expert biostatisticians. In addition, they have practical experience designing adaptive trials for some of the leading biopharmaceutical companies in the industry. They will draw on this experience to cover topics on:

  • Sample size re estimation
  • Preserving Type 1 Error
  • Computing Power
  • Obtaining Point Estimates
  • Computing Confidence Intervals

Those interested in learning about new technology for trial forecasting, prediction and dose-escalation are also welcome to use this opportunity to learn about the recently released East 6.3.



Curious about Cytel Consulting’s approach?

 Designing adaptive trials?

Explore the videos below:


Adaptive Sample Size Re-Estimation in the VALOR Trial:




Adaptive 2-stage Design Supporting the Fulyzaq® Approval:



Adaptive Trials in the Exploratory Stage:



Topics: Adaptive Clinical Trials

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.


Posts by Topic

see all

Recent Posts